| RS1555985649 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1555985687 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS1555985689 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1555985742 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1555985745 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1555985780 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1555985799 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1555985814 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS1555985820 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1555985827 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1555985829 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1555985830 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS1555985855 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1555985864 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1555986221 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS1555986267 |
MBTPS2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, type 19 |
| RS1555986287 |
MBTPS2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, type 19 |
| RS1555986305 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1555986307 |
GLA
|
Health Risk |
Pathogenic |
— |
| RS1555986860 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1555986950 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1555987080 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Cardiovascular phenotype |
| RS1555987101 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1555987107 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1555987150 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1555987162 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1555987175 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1555987214 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1555987215 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1555987232 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1555987647 |
NF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 2 |
| RS1555987732 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |
| RS1555988071 |
PHKA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1555988204 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation |
| RS1555988314 |
HNRNPH2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS1555988317 |
OPHN1
|
Health Risk |
Pathogenic |
— |
| RS1555988382 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 2B, Infantile neuroaxonal dystrophy |
| RS1555988404 |
HNRNPH2
|
Health Risk |
Pathogenic |
— |
| RS1555988417 |
HNRNPH2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1555988422 |
HNRNPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS1555988479 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Thyroid cancer |
| RS1555988730 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS1555989321 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CASK-related |
| RS1555989329 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CASK-related |
| RS1555989338 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS1555989364 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS1555989375 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS1555989523 |
PHKA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1555989715 |
SLC16A2
|
Health Risk |
Pathogenic |
— |
| RS1555989729 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS1555989846 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS1555990320 |
SLC16A2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555990470 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1555990478 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1555990485 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1555990488 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1555990751 |
DYRK1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555990805 |
DYRK1A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1555990816 |
DYRK1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555990855 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1555990946 |
DYRK1A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1555990955 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1555990958 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, Complex neurodevelopmental disorder |
| RS1555991325 |
DYRK1A
|
Health Risk |
Likely pathogenic |
— |
| RS1555991936 |
HDAC8
|
Health Risk |
Pathogenic |
— |
| RS1555991965 |
HDAC8
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555992948 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1555993038 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1555993215 |
HDAC8
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555993243 |
HDAC8
|
Health Risk |
Pathogenic |
— |
| RS1555993293 |
NF2
|
Health Risk |
Likely pathogenic |
Ependymoma, Ependymoma |
| RS1555993301 |
NF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 2 |
| RS1555993313 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1555993323 |
TBX22
|
Health Risk |
Likely pathogenic |
— |
| RS1555993336 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1555993345 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1555993352 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |
| RS1555994573 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1555994816 |
NF2
|
Health Risk |
Likely pathogenic |
— |
| RS1555994819 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1555994836 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1555994854 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1555995130 |
DYRK1A
|
Health Risk |
Likely pathogenic |
— |
| RS1555995635 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1555995689 |
PHKA2
|
Health Risk |
Likely pathogenic |
— |
| RS1555995750 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS1555995816 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS1555995822 |
AR
|
Health Risk |
Likely pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS1555995840 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1555995842 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS1555995848 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1555995851 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Differences in sex development |
| RS1555995865 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS1555995877 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS1555996156 |
NF2
|
Health Risk |
Pathogenic |
— |
| RS1555996218 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1555996810 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1555996855 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS1555996863 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1555996867 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |